Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04707638|
Recruitment Status : Withdrawn (Ethics application has not been completed yet)
First Posted : January 13, 2021
Last Update Posted : February 3, 2021
|Condition or disease||Intervention/treatment|
|Parkinson Disease Dystonia||Other: No intervention used|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||0 participants|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS) Under General Anesthesia for Patients With Parkinson's Disease or Dystonia and Their Correlation With Prognosis|
|Actual Study Start Date :||January 1, 2021|
|Estimated Primary Completion Date :||January 11, 2023|
|Estimated Study Completion Date :||January 11, 2023|
Parkinson's disease or dystonia patients
Patients with Parkinson's disease or dystonia and underwent STN DBS under general anesthesia in neurosurgery department
Other: No intervention used
No intervention used
- Unified Parkinson's Disease Rating Scale (UPDRS) [ Time Frame: Two years postoperatively ]UPDRS has four parts: part I (nonmotor experiences of daily living, total score=16); part II (patient motor experience of daily living, total score=52); part III (clinician motor examination, total score=56); part IV (complications, total score=23). The total score of all the four parts is147. Higher scores means a worse outcome.
- Burke Fahn Marsden's Dystonia Rating Scales(BFMDRS) [ Time Frame: Two years postoperatively ]BFMDRS has two parts: BFMDRS movement part (BFMDRS-M) and BFMDRS disability part (BFMDRS-D). The total score of BFMDRS-M is 120 and the total score of BFMDRS-D is 30. Higher scores means a worse outcome.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04707638
|Principal Investigator:||Fu Peng, PHD||Neurosurgery department of Wuhan Union Hospital|